Cohance Lifesciences Limited
COHANCE
Rank in Stocks
#6340
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Share Price
$5.09
Market Cap
$1.95B
Change (1 day)
0.79%
Change (1 year)
-57.04%
Country
IN
Trade Cohance Lifesciences Limited (COHANCE)
Category
Healthcare
Revenue for Cohance Lifesciences Limited (COHANCE)
Revenue in Jun 2025 TTM: $176.91M
According to Cohance Lifesciences Limited latest financial reports the company's current revenue (TTM) is $176.91M. In 2024 the company made a revenue of $126.09M a decrease compared to the revenue in the year 2023 that was $163.10M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Cohance Lifesciences Limited from 2019 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2026 (TTM) | $176.91M | 26.34% |
| 2025 | $140.02M | 11.05% |
| 2024 | $126.09M | -22.69% |
| 2023 | $163.10M | -4.01% |
| 2022 | $169.91M | 26.93% |
| 2021 | $133.86M | 24.97% |
| 2020 | $107.11M | 103.08% |
| 2019 | $52.74M | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | 3,637.27% |
IN
|
